4//SEC Filing
Coffin James 4
Accession 0001209191-21-048230
CIK 0001818331other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 6:53 PM ET
Size
10.9 KB
Accession
0001209191-21-048230
Insider Transaction Report
Form 4
Coffin James
President and COO
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-07-22+480,657→ 480,657 totalExercise: $0.77Exp: 2030-02-17→ Class A Common Stock (480,657 underlying) - Award
Employee Stock Option (Right to Buy)
2021-07-22+332,963→ 332,963 totalExercise: $0.77Exp: 2030-02-17→ Class A Common Stock (332,963 underlying) - Award
Employee Stock Option (Right to Buy)
2021-07-22+2,167,093→ 2,167,093 totalExercise: $0.15Exp: 2027-08-30→ Class A Common Stock (2,167,093 underlying)
Footnotes (2)
- [F1]6.25% of the total shares underlying the option vest in quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F2]Pursuant to the business combination between the Issuer (which was formerly known as CM Life Sciences, Inc.) and Mount Sinai Genomics, Inc. d/b/a Sema4 ("Sema4"), each share of Sema4 outstanding common stock was automatically converted into the right to shares of the Issuer's Class A Common Stock based on a 1 to 123.8338 exchange ratio ("Exchange Ratio"). In addition, each outstanding Sema4 equity award was automatically converted into a corresponding equity award of the Issuer based on the Exchange Ratio and with the same terms and vesting conditions as the Sema4 equity awards.
Documents
Issuer
Sema4 Holdings Corp.
CIK 0001818331
Entity typeother
Related Parties
1- filerCIK 0001873883
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 6:53 PM ET
- Size
- 10.9 KB